Skip to main content
. Author manuscript; available in PMC: 2012 Aug 15.
Published in final edited form as: Bioorg Med Chem Lett. 2011 Jun 22;21(16):4753–4757. doi: 10.1016/j.bmcl.2011.06.069

Figure 3.

Figure 3

The MALDI-MS analysis of the following samples: (a) The assay mixture from compound 1 with SIRT1 and NAD+; (b) The assay mixture from compound 1 with NAD+ in the absence of SIRT1; (c) The assay mixture from NAD+ with SIRT1 in the absence of compound 1; (d) the MALDI matrix 3-hydroxypicolinic acid (3-HPA) only. All the MALDI-MS analyses were performed in a negative reflector mode. See ref. 67 for further experimental conditions.